The EU did a Brexit trade deal with the pharma industry: it tried to lock in a perceived short-term price advantage at the expense of everything else. Instead of prioritising the speed and security of supplies at any price, the EU prioritised the price. The EU paid 24% less for the Pfizer vaccine than the US, for example. For the Oxford/AstraZeneca vaccine, the price gap is 45%. The UK almost certainly paid a lot more. It is no wonder that the manufacturers are prioritising orders on a first-come, first-serve basis, and from countries that pay the full price. The price difference is macroeconomically irrelevant. But if vaccine shortages lead to longer lockdowns, the indirect effect of that short-sighted policy will be massive.
Related Articles
The Electronic Intifada: EU funds weapons firm playing “pivotal role” in Gaza genocide
The European Union approved the participation of a major Israeli weapons firm in a new science project during the current genocidal war against Gaza. The state-owned Israel Aerospace Industries (IAI) is part of the consortium […]
Vila Web: Catalan education sector protests against Spanish quota in the classrooms
Teachers and students go on strike for fourth day in March, as government confirms not imposing ruling Read Here
Joseph Healy: Transforming Politics from the Left – A new Left party Transform
Interesting initiative in the UK to launch a new socialist party. In ‘International Viewpoint’. Read the article HERE.
Be the first to comment